Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil.

Alanazi FK, Haq N, Radwan AA, Alsarra IA, Shakeel F.

Pharm Dev Technol. 2015 May;20(3):266-70. doi: 10.3109/10837450.2013.860551. Epub 2013 Nov 25.

PMID:
24266739
2.

Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.

Shakeel F, Haq N, Al-Dhfyan A, Alanazi FK, Alsarra IA.

Drug Deliv. 2015;22(4):573-80. doi: 10.3109/10717544.2013.868557. Epub 2013 Dec 18.

PMID:
24350612
3.

Novel formulation of a methotrexate derivative with a lipid nanoemulsion.

Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhão RC.

Int J Nanomedicine. 2011;6:2285-95. doi: 10.2147/IJN.S18039. Epub 2011 Oct 12.

4.

Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug.

Macedo AS, Quelhas S, Silva AM, Souto EB.

Pharm Dev Technol. 2014 Sep;19(6):677-80. doi: 10.3109/10837450.2013.823989. Epub 2013 Aug 12.

PMID:
23930932
5.

Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.

Sharma S, Sahni JK, Ali J, Baboota S.

Drug Deliv. 2015;22(4):541-51. doi: 10.3109/10717544.2014.893382. Epub 2014 Mar 13.

PMID:
24625264
6.

Nanoemulsions as vehicles for transdermal delivery of aceclofenac.

Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S.

AAPS PharmSciTech. 2007 Dec 14;8(4):E104. doi: 10.1208/pt0804104.

7.

Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.

Patel MN, Lakkadwala S, Majrad MS, Injeti ER, Gollmer SM, Shah ZA, Boddu SH, Nesamony J.

AAPS PharmSciTech. 2014 Dec;15(6):1498-508. doi: 10.1208/s12249-014-0168-x. Epub 2014 Jul 18.

8.

5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.

Ocal H, Arica-Yegin B, Vural I, Goracinova K, Caliş S.

Drug Dev Ind Pharm. 2014 Apr;40(4):560-7. doi: 10.3109/03639045.2013.775581. Epub 2013 Apr 18.

PMID:
23596973
9.

Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation.

Dasgupta S, Dey S, Choudhury S, Mazumder B.

Expert Opin Drug Deliv. 2013 Apr;10(4):411-20. doi: 10.1517/17425247.2013.749234. Epub 2013 Jan 15.

PMID:
23316798
10.

Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery.

Ledet G, Pamujula S, Walker V, Simon S, Graves R, Mandal TK.

Drug Dev Ind Pharm. 2014 Mar;40(3):370-9. doi: 10.3109/03639045.2012.763137. Epub 2013 Apr 19.

11.

Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process.

Kelmann RG, Kuminek G, Teixeira HF, Koester LS.

Int J Pharm. 2007 Sep 5;342(1-2):231-9. Epub 2007 May 13.

PMID:
17582711
12.

L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.

Mishra BJ, Kaul A, Trivedi P.

Drug Deliv. 2015 Feb;22(2):214-22. doi: 10.3109/10717544.2014.883117. Epub 2014 Feb 14.

PMID:
24524408
13.

Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation.

Nesamony J, Shah IS, Kalra A, Jung R.

Drug Dev Ind Pharm. 2014 Sep;40(9):1253-63. doi: 10.3109/03639045.2013.814065. Epub 2013 Jul 9.

PMID:
23837519
14.

Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.

Rajpoot P, Bali V, Pathak K.

Int J Pharm. 2012 Apr 15;426(1-2):219-30. doi: 10.1016/j.ijpharm.2012.01.027. Epub 2012 Jan 24.

PMID:
22301424
15.

PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.

Li X, Xu Y, Chen G, Wei P, Ping Q.

Drug Dev Ind Pharm. 2008 Jan;34(1):107-15. doi: 10.1080/03639040701484593 .

PMID:
18214762
16.

Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.

Puri R, Jain S.

Anticancer Drugs. 2012 Oct;23(9):923-34. doi: 10.1097/CAD.0b013e3283534051.

PMID:
22926258
17.

In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application.

Dasgupta S, Ghosh SK, Ray S, Kaurav SS, Mazumder B.

Curr Drug Deliv. 2014;11(1):132-8.

PMID:
24266509
18.

Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.

Teixeira RS, Valduga CJ, Benvenutti LA, Schreier S, Maranhão RC.

J Pharm Pharmacol. 2008 Oct;60(10):1287-95. doi: 10.1211/jpp/60.10.0004.

PMID:
18812021
19.

Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.

Neupane YR, Srivastava M, Ahmad N, Kumar N, Bhatnagar A, Kohli K.

Int J Pharm. 2014 Dec 30;477(1-2):601-12. doi: 10.1016/j.ijpharm.2014.11.001. Epub 2014 Nov 6.

PMID:
25445972
20.

Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.

Wang M, Yuan Y, Gao Y, Ma HM, Xu HT, Zhang XN, Pan WS.

Drug Dev Ind Pharm. 2012 Sep;38(9):1134-41. doi: 10.3109/03639045.2011.641565. Epub 2011 Dec 19.

PMID:
22182601
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk